Dr. Jackie Douglas

Dr. Jackie Douglas, a medical oncology fellow at Johns Hopkins specializing in neoantigens and cancer immunotherapy, dives into the promising world of personalized cancer treatments. She explains how neoantigens, unique to cancer cells, can be targeted for therapy. The discussion includes HLA alleles' roles, challenges like patient variability, and the exciting potential of mRNA vaccines in clinical trials. Douglas emphasizes the need for affordable therapies and shares insights on future advancements, all while maintaining a hopeful outlook for cancer patients.